BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
3.880
+0.730 (23.17%)
At close: May 29, 2025, 4:00 PM
3.800
-0.080 (-2.06%)
Pre-market: May 30, 2025, 4:38 AM EDT
BioNexus Gene Lab Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -2.12 | -1.6 | -2.63 | -0.36 | 0.75 | 1.09 | Upgrade
|
| Depreciation & Amortization | 0.16 | 0.15 | 0.11 | 0.11 | 0.11 | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.71 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.04 | 0.04 | 0 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0 | -0.11 | -0.31 | 0.07 | 0.03 | -0.03 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.87 | -0.8 | 0.95 | 0 | 0 | 0 | Upgrade
|
| Other Operating Activities | -0.04 | -0.04 | -0.06 | -0.11 | -0.02 | -0.01 | Upgrade
|
| Change in Accounts Receivable | 0.15 | 0.15 | 0.65 | 0.54 | 0.58 | 0.41 | Upgrade
|
| Change in Inventory | -0.1 | -0.25 | -0.16 | 0.54 | -0.35 | 0.15 | Upgrade
|
| Change in Accounts Payable | -0.17 | 0.2 | -0.38 | -0.12 | -1.18 | -0.52 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.08 | 0.08 | - | Upgrade
|
| Change in Income Taxes | -0.05 | -0.04 | -0.04 | 0.01 | 0.07 | 0.03 | Upgrade
|
| Change in Other Net Operating Assets | -0.02 | 0.05 | 0.05 | -0.07 | -0.06 | 0.04 | Upgrade
|
| Operating Cash Flow | -3.02 | -2.23 | -1.82 | 0.55 | 0.01 | 0.55 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 5923.60% | -98.34% | - | Upgrade
|
| Capital Expenditures | -0.21 | -0.23 | -0.15 | -0.05 | -0 | -0.42 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 1.47 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 0.35 | Upgrade
|
| Investment in Securities | 0.54 | 0.58 | -0.29 | -0.51 | -0.51 | -0.08 | Upgrade
|
| Other Investing Activities | 0.07 | 0.07 | -1.35 | 0.12 | 0.02 | 0.01 | Upgrade
|
| Investing Cash Flow | 0.4 | 0.42 | -1.79 | -0.45 | -0.49 | 1.32 | Upgrade
|
| Short-Term Debt Issued | - | 0 | 0.01 | - | - | - | Upgrade
|
| Total Debt Issued | -0.02 | 0 | 0.01 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.03 | -0.03 | -0 | Upgrade
|
| Total Debt Repaid | -0 | - | - | -0.03 | -0.03 | -0 | Upgrade
|
| Net Debt Issued (Repaid) | -0.02 | 0 | 0.01 | -0.03 | -0.03 | -0 | Upgrade
|
| Issuance of Common Stock | 0.14 | 0.14 | 6.26 | 0.15 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -0.01 | - | - | Upgrade
|
| Financing Cash Flow | 0.12 | 0.14 | 6.27 | 0.11 | -0.03 | -0 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.16 | 0.04 | -0.26 | -0.21 | -0.15 | 0.06 | Upgrade
|
| Net Cash Flow | -2.35 | -1.63 | 2.4 | -0.01 | -0.66 | 1.93 | Upgrade
|
| Free Cash Flow | -3.24 | -2.46 | -1.97 | 0.5 | 0.01 | 0.13 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 8195.57% | -95.42% | - | Upgrade
|
| Free Cash Flow Margin | -34.92% | -25.88% | -20.18% | 4.55% | 0.04% | 1.15% | Upgrade
|
| Free Cash Flow Per Share | -1.74 | -1.38 | -1.24 | 0.34 | 0.00 | 0.15 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Cash Income Tax Paid | 0.03 | 0.04 | 0.07 | 0.17 | 0.23 | 0.13 | Upgrade
|
| Levered Free Cash Flow | -2.54 | -1.91 | -0.57 | 0.73 | -0.11 | -1.84 | Upgrade
|
| Unlevered Free Cash Flow | -2.53 | -1.9 | -0.56 | 0.73 | -0.1 | -1.83 | Upgrade
|
| Change in Net Working Capital | 1.03 | 0.64 | -1.38 | -0.82 | 0.87 | 1.87 | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.